NFE2L2 and Alzheimer disease: Overall, all the above-mentioned findings in diseased individuals and animal models strengthen the link between Nrf2 and neurodegeneration suggesting the modulation of the transcription factor as an important potential therapeutic target for AD; this will be considered in detail below, along with the action of other protective compounds.